Parexel announces PAREXEL® Access, a service that is directed toward clients’ market access and ongoing commercial success.
Parexel announces PAREXEL® Access, a service that is directed toward clients’ market access and ongoing commercial success. PAREXEL Access combines the expertise of HERON™ Commercialization, QSI’s pharmacovigilance, PAREXEL Medical Communications, and PAREXEL Peri-/Post-approval services, which focuses on clinical research and operations, market access consulting, medical communications, and pharmacovigilance to help companies identify, evaluate, generate and communicate the evidence of its product.
